跳轉至內容
Merck
  • Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models.

Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models.

STAR protocols (2021-09-07)
Irina N Marinova, Hans H Wandall, Sally Dabelsteen
摘要

Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/TERT-1) to study the role of glycans in epithelial tissue formation. This strategy is also applicable to other gene targets and organotypic tissue models. Careful handling of the cell cultures is critical for the successful formation of the organoids. For complete details on the use and execution of this protocol, please refer to Dabelsteen et al. (2020).

材料
產品編號
品牌
產品描述

Sigma-Aldrich
二甲基亚砜, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
胰岛素 来源于牛胰腺, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
氢化可的松, BioReagent, suitable for cell culture
Sigma-Aldrich
腺嘌呤, ≥99%
Sigma-Aldrich
霍乱毒素 A亚基 来源于霍乱弧菌, lyophilized powder
Sigma-Aldrich
3,3′,5-三碘-L-甲状腺氨酸 钠盐, ≥95% (HPLC)